We are live on ! Find out more
TCM

Tygh Capital Management Portfolio holdings

AUM $782M
1-Year Est. Return 39.44%
This Fund
S&P 500
This Quarter Est. Return
+7.88%
1 Year Est. Return
+39.44%
3 Year Est. Return
+251.35%
5 Year Est. Return
+417.76%
10 Year Est. Return
–
AUM
$734M
AUM Growth
+$26.7M
Cap. Flow
-$21.2M
Cap. Flow %
-2.89%
Top 10 Hldgs %
21.46%
Holding
99
New
12
Increased
14
Reduced
62
Closed
11

Top Buys

Rank Stock Value
1
KEX icon
Kirby Corp
KEX
+$9.85M
2
RPD icon
Rapid7
RPD
+$9.17M
3
PACW
PacWest Bancorp
PACW
+$7.78M
4
PNTG icon
Pennant Group
PNTG
+$7.64M
5
HQY icon
HealthEquity
HQY
+$7.6M

Top Sells

Rank Stock Value
1
TFII icon
TFI International
TFII
+$9.1M
2
WAL icon
Western Alliance Bancorporation
WAL
+$8.3M
3
SHYF
The Shyft Group
SHYF
+$8.15M
4
VERX icon
Vertex
VERX
+$7.45M
5
MRCY icon
Mercury Systems
MRCY
+$6.8M

Sector Composition

Rank Sector Weight
1 Technology 27.75%
2 Healthcare 23.32%
3 Industrials 19.7%
4 Consumer Discretionary 13.08%
5 Materials 5.31%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ZYXI
76
DELISTED
Zynex
ZYXI
$3.43M 0.47%
242,877
-2,640
-1% -$36.5K
HALO icon
77
Halozyme
HALO
$9.91B
$3.4M 0.46%
74,825
-748
-1% -$33.1K
ALG icon
78
Alamo Group
ALG
$2.03B
$3.34M 0.46%
21,900
+17,366
+383% +$2.69M
FATE icon
79
Fate Therapeutics
FATE
$288M
$3.16M 0.43%
36,415
-388
-1% -$31.3K
BPMC
80
DELISTED
Blueprint Medicines
BPMC
$2.93M 0.4%
33,274
-348
-1% -$31.9K
RARE icon
81
Ultragenyx Pharmaceutical
RARE
$2.48B
$2.88M 0.39%
30,152
-316
-1% -$32.9K
BHVN
82
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
$2.8M 0.38%
28,808
-294
-1% -$23.9K
NVTA
83
DELISTED
Invitae Corporation
NVTA
$2.08M 0.28%
61,564
-643
-1% -$20.9K
PTCT icon
84
PTC Therapeutics
PTCT
$5.84B
$1.62M 0.22%
38,283
-396
-1% -$17K
KYNB
85
Kyntra Bio
KYNB
$28.3M
$1.31M 0.18%
1,970
-17
-0.9% -$9.79K
ADUS icon
86
Addus HomeCare
ADUS
$2.19B
$1.31M 0.18%
15,000
-38,500
-72% -$3.74M
ASPN icon
87
Aspen Aerogels
ASPN
$635M
$1.26M 0.17%
+42,099
New +$859K
AVNS
88
DELISTED
Avanos Medical
AVNS
$655K 0.09%
18,000
-94,535
-84% -$3.91M
CGNT icon
89
Cognyte Software
CGNT
$674M
– –
-192,838
Closed -$5.36M
EGHT icon
90
8x8 Inc
EGHT
$315M
– –
-164,367
Closed -$5.33M
FOLD
91
DELISTED
Amicus Therapeutics
FOLD
– –
-135,510
Closed -$1.34M
MRCY icon
92
Mercury Systems
MRCY
$6.6B
– –
-96,226
Closed -$6.8M
OSUR icon
93
OraSure Technologies
OSUR
$270M
– –
-283,526
Closed -$3.31M
PLSE icon
94
Pulse Biosciences
PLSE
$2.67B
– –
-125,266
Closed -$2.97M
RGEN icon
95
Repligen
RGEN
$9B
– –
-24,796
Closed -$4.82M
ROOT icon
96
Root
ROOT
$775M
– –
-12,371
Closed -$2.83M
TREE icon
97
LendingTree
TREE
$469M
– –
-18,401
Closed -$3.92M
TTD icon
98
Trade Desk
TTD
$8.39B
– –
-60,930
Closed -$3.97M
VERX icon
99
Vertex
VERX
$1.9B
– –
-339,117
Closed -$7.45M
1 2 3
4

Similar funds

IVP
IA Venture Partners New York $785M AUM
FMBTD
First Midwest Bank Trust Division Joliet, Illinois $777M AUM 29.48% 1-Year Est. Return
EHPM
Emery Howard Portfolio Management Burlingame, California $773M AUM 18.85% 1-Year Est. Return
VMV
Venrock Management V Palo Alto, California $719M AUM
SIM
SCGF III Management Menlo Park, California $673M AUM
HAM
Hillcrest Asset Management Plano, Texas $656M AUM 31.12% 1-Year Est. Return
VIMU
Veritas Investment Management (UK) London, United Kingdom $648M AUM 36.52% 1-Year Est. Return
AC
Alley Company Lake Forest, Illinois $631M AUM 24.9% 1-Year Est. Return

Tygh Capital Management's Q2 2021 Portfolio in Review

As of Q2 2021, Tygh Capital Management held 99 positions worth $734M, up 3.8% from $707M the previous quarter. Its ten largest holdings account for 21% of the portfolio.

Tygh Capital Management's Q2 2021 filing shows 12 new, 14 increased, 62 reduced and 11 closed positions. Its largest new stake was Kirby Corp: 152,865 shares worth $9.27M. The largest sale was TFI International, an estimated $9.1M.

By sector, the portfolio is most concentrated in Technology at 28% of assets, down from 29% a quarter earlier, followed by Healthcare and Industrials.

  • Tygh Capital Management's largest Q2 2021 buy was Kirby Corp: 152,865 shares worth $9.27M.
  • Tygh Capital Management added most to NeoGenomics in Q2 2021, an estimated $6.04M increase.
  • Tygh Capital Management's biggest Q2 2021 reduction was TFI International, cutting an estimated $9.1M.
  • Tygh Capital Management fully exited Vertex in Q2 2021, selling an estimated $7.45M.
  • Tygh Capital Management's ten largest holdings make up 21% of its $734M portfolio in Q2 2021.
  • Tygh Capital Management opened 12 new positions and closed 11 in Q2 2021.
  • Tygh Capital Management's portfolio value rose 3.8% quarter-over-quarter to $734M.

Based on Tygh Capital Management's 13F filing for Q2 2021, filed 11 Aug 2021.